EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC 3.0

Network Pharmacology Followed by Experimental Validation to Explore the Mechanism of Stigmasterol in Sangbaipi Decoction Regulating PI3K/Akt Signaling to Alleviate Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Haidong He, Shuihua Sun, Weihua Xu, Mingwan Zhang

International Journal of Chronic Obstructive Pulmonary Disease · 2024

DOI: 10.2147/copd.s459814 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2024. Verfasst von Haidong He und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Tongde Hospital of Zhejiang Province, Hangzhou City, Zhejiang Province, People's Republic of Chin…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Lung, Network Pharmacology, Phosphatidylinositol 3-Kinase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: 2023 Zhejiang TCM Science and Technology Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalLungNetwork PharmacologyPhosphatidylinositol 3-KinaseProto-Oncogene Proteins c-aktPulmonary Disease, Chronic ObstructiveStigmasterolAnimalsMaleRatsAnti-Inflammatory AgentsChromonesCytokinesDisease Models, AnimalDisease ProgressionInflammation MediatorsLipopolysaccharidesMolecular Docking SimulationPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProtein Interaction MapsRats, Sprague-DawleyReproducibility of ResultsSignal Transduction

Stichwörter der Autor:innen

PI3K/Akt signalingacute exacerbation of chronic obstructive pulmonary diseaselung inflammationsangbaipi decoctionstigmasterol

Substanzen

Anti-Inflammatory AgentsChromonesCytokinesDrugs, Chinese HerbalInflammation MediatorsLipopolysaccharidesPhosphatidylinositol 3-KinasePhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Tongde Hospital of Zhejiang Province, Hangzhou City, Zhejiang Province, People's Republic of China.
  • Department of Medical Oncology, Tongde Hospital of Zhejiang Province, Hangzhou City, Zhejiang Province, People's Republic of China.
  • Department of Pharmacy, Tongde Hospital of Zhejiang Province, Hangzhou City, Zhejiang Province, People's Republic of China.

Förderung

  • 2023 Zhejiang TCM Science and Technology Plan

Zitieren

APA

He, H., Sun, S., Xu, W., & Zhang, M. (2024). Network Pharmacology Followed by Experimental Validation to Explore the Mechanism of Stigmasterol in Sangbaipi Decoction Regulating PI3K/Akt Signaling to Alleviate Acute Exacerbation of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s459814

Vancouver

He H, Sun S, Xu W, Zhang M. Network Pharmacology Followed by Experimental Validation to Explore the Mechanism of Stigmasterol in Sangbaipi Decoction Regulating PI3K/Akt Signaling to Alleviate Acute Exacerbation of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease. 2024. doi:10.2147/copd.s459814

BibTeX
@article{He2024,
  author = {He, Haidong and Sun, Shuihua and Xu, Weihua and Zhang, Mingwan},
  title = {Network Pharmacology Followed by Experimental Validation to Explore the Mechanism of Stigmasterol in Sangbaipi Decoction Regulating PI3K/Akt Signaling to Alleviate Acute Exacerbation of Chronic Obstructive Pulmonary Disease},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2024},
  doi = {10.2147/copd.s459814}
}
Kostenlos starten →